Antimicrobial Activity of the Green Tea Polyphenol (−)-Epigallocatechin-3-Gallate (EGCG) against Clinical Isolates of Multidrug-Resistant <i>Vibrio cholerae</i>

The spread of multidrug-resistant (MDR) <i>Vibrio cholerae</i> necessitates the development of novel prevention and treatment strategies. This study aims to evaluate the in vitro antibacterial activity of green tea polyphenol (−)-epigallocatechin-3-gallate (EGCG) against MDR <i>V....

Full description

Bibliographic Details
Main Authors: Achiraya Siriphap, Anong Kiddee, Acharaporn Duangjai, Atchariya Yosboonruang, Grissana Pook-In, Surasak Saokaew, Orasa Sutheinkul, Anchalee Rawangkan
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/11/4/518
_version_ 1797437127517011968
author Achiraya Siriphap
Anong Kiddee
Acharaporn Duangjai
Atchariya Yosboonruang
Grissana Pook-In
Surasak Saokaew
Orasa Sutheinkul
Anchalee Rawangkan
author_facet Achiraya Siriphap
Anong Kiddee
Acharaporn Duangjai
Atchariya Yosboonruang
Grissana Pook-In
Surasak Saokaew
Orasa Sutheinkul
Anchalee Rawangkan
author_sort Achiraya Siriphap
collection DOAJ
description The spread of multidrug-resistant (MDR) <i>Vibrio cholerae</i> necessitates the development of novel prevention and treatment strategies. This study aims to evaluate the in vitro antibacterial activity of green tea polyphenol (−)-epigallocatechin-3-gallate (EGCG) against MDR <i>V. cholerae</i>. First, MIC and MBC values were evaluated by broth microdilution techniques against 45 <i>V. cholerae</i> strains. The checkerboard assay was then used to determine the synergistic effect of EGCG and tetracycline. The pharmaceutical mode of action of EGCG was clarified by time-killing kinetics and membrane disruption assay. Our results revealed that all of the 45 clinical isolates were susceptible to EGCG, with MIC and MBC values in the range of 62.5–250 µg/mL and 125–500 µg/mL, respectively. Furthermore, the combination of EGCG and tetracycline was greater than either treatment alone, with a fractional inhibitory concentration index (FICI) of 0.009 and 0.018 in the O1 and O139 representative serotypes, respectively. Time-killing kinetics analysis suggested that EGCG had bactericidal activity for MDR <i>V. cholerae</i> after exposure to at least 62.5 µg/mL EGCG within 1 h. The mode of action of EGCG might be associated with membrane disrupting permeability, as confirmed by scanning electron microscopy. This is the first indication that EGCG is a viable anti-MDR <i>V. cholerae</i> treatment.
first_indexed 2024-03-09T11:15:24Z
format Article
id doaj.art-dda795f77fd24f12b35eda5c8e6cdd7f
institution Directory Open Access Journal
issn 2079-6382
language English
last_indexed 2024-03-09T11:15:24Z
publishDate 2022-04-01
publisher MDPI AG
record_format Article
series Antibiotics
spelling doaj.art-dda795f77fd24f12b35eda5c8e6cdd7f2023-12-01T00:33:16ZengMDPI AGAntibiotics2079-63822022-04-0111451810.3390/antibiotics11040518Antimicrobial Activity of the Green Tea Polyphenol (−)-Epigallocatechin-3-Gallate (EGCG) against Clinical Isolates of Multidrug-Resistant <i>Vibrio cholerae</i>Achiraya Siriphap0Anong Kiddee1Acharaporn Duangjai2Atchariya Yosboonruang3Grissana Pook-In4Surasak Saokaew5Orasa Sutheinkul6Anchalee Rawangkan7School of Medical Sciences, University of Phayao, Phayao 56000, ThailandSchool of Medical Sciences, University of Phayao, Phayao 56000, ThailandSchool of Medical Sciences, University of Phayao, Phayao 56000, ThailandSchool of Medical Sciences, University of Phayao, Phayao 56000, ThailandSchool of Medical Sciences, University of Phayao, Phayao 56000, ThailandDepartment of Pharmaceutical Care, Division of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, University of Phayao, Phayao 56000, ThailandFaculty of Public Health, Mahidol University, Bangkok 10400, ThailandSchool of Medical Sciences, University of Phayao, Phayao 56000, ThailandThe spread of multidrug-resistant (MDR) <i>Vibrio cholerae</i> necessitates the development of novel prevention and treatment strategies. This study aims to evaluate the in vitro antibacterial activity of green tea polyphenol (−)-epigallocatechin-3-gallate (EGCG) against MDR <i>V. cholerae</i>. First, MIC and MBC values were evaluated by broth microdilution techniques against 45 <i>V. cholerae</i> strains. The checkerboard assay was then used to determine the synergistic effect of EGCG and tetracycline. The pharmaceutical mode of action of EGCG was clarified by time-killing kinetics and membrane disruption assay. Our results revealed that all of the 45 clinical isolates were susceptible to EGCG, with MIC and MBC values in the range of 62.5–250 µg/mL and 125–500 µg/mL, respectively. Furthermore, the combination of EGCG and tetracycline was greater than either treatment alone, with a fractional inhibitory concentration index (FICI) of 0.009 and 0.018 in the O1 and O139 representative serotypes, respectively. Time-killing kinetics analysis suggested that EGCG had bactericidal activity for MDR <i>V. cholerae</i> after exposure to at least 62.5 µg/mL EGCG within 1 h. The mode of action of EGCG might be associated with membrane disrupting permeability, as confirmed by scanning electron microscopy. This is the first indication that EGCG is a viable anti-MDR <i>V. cholerae</i> treatment.https://www.mdpi.com/2079-6382/11/4/518antimicrobial activityEGCGgreen teaMDR<i>Vibrio cholerae</i>
spellingShingle Achiraya Siriphap
Anong Kiddee
Acharaporn Duangjai
Atchariya Yosboonruang
Grissana Pook-In
Surasak Saokaew
Orasa Sutheinkul
Anchalee Rawangkan
Antimicrobial Activity of the Green Tea Polyphenol (−)-Epigallocatechin-3-Gallate (EGCG) against Clinical Isolates of Multidrug-Resistant <i>Vibrio cholerae</i>
Antibiotics
antimicrobial activity
EGCG
green tea
MDR
<i>Vibrio cholerae</i>
title Antimicrobial Activity of the Green Tea Polyphenol (−)-Epigallocatechin-3-Gallate (EGCG) against Clinical Isolates of Multidrug-Resistant <i>Vibrio cholerae</i>
title_full Antimicrobial Activity of the Green Tea Polyphenol (−)-Epigallocatechin-3-Gallate (EGCG) against Clinical Isolates of Multidrug-Resistant <i>Vibrio cholerae</i>
title_fullStr Antimicrobial Activity of the Green Tea Polyphenol (−)-Epigallocatechin-3-Gallate (EGCG) against Clinical Isolates of Multidrug-Resistant <i>Vibrio cholerae</i>
title_full_unstemmed Antimicrobial Activity of the Green Tea Polyphenol (−)-Epigallocatechin-3-Gallate (EGCG) against Clinical Isolates of Multidrug-Resistant <i>Vibrio cholerae</i>
title_short Antimicrobial Activity of the Green Tea Polyphenol (−)-Epigallocatechin-3-Gallate (EGCG) against Clinical Isolates of Multidrug-Resistant <i>Vibrio cholerae</i>
title_sort antimicrobial activity of the green tea polyphenol epigallocatechin 3 gallate egcg against clinical isolates of multidrug resistant i vibrio cholerae i
topic antimicrobial activity
EGCG
green tea
MDR
<i>Vibrio cholerae</i>
url https://www.mdpi.com/2079-6382/11/4/518
work_keys_str_mv AT achirayasiriphap antimicrobialactivityofthegreenteapolyphenolepigallocatechin3gallateegcgagainstclinicalisolatesofmultidrugresistantivibriocholeraei
AT anongkiddee antimicrobialactivityofthegreenteapolyphenolepigallocatechin3gallateegcgagainstclinicalisolatesofmultidrugresistantivibriocholeraei
AT acharapornduangjai antimicrobialactivityofthegreenteapolyphenolepigallocatechin3gallateegcgagainstclinicalisolatesofmultidrugresistantivibriocholeraei
AT atchariyayosboonruang antimicrobialactivityofthegreenteapolyphenolepigallocatechin3gallateegcgagainstclinicalisolatesofmultidrugresistantivibriocholeraei
AT grissanapookin antimicrobialactivityofthegreenteapolyphenolepigallocatechin3gallateegcgagainstclinicalisolatesofmultidrugresistantivibriocholeraei
AT surasaksaokaew antimicrobialactivityofthegreenteapolyphenolepigallocatechin3gallateegcgagainstclinicalisolatesofmultidrugresistantivibriocholeraei
AT orasasutheinkul antimicrobialactivityofthegreenteapolyphenolepigallocatechin3gallateegcgagainstclinicalisolatesofmultidrugresistantivibriocholeraei
AT anchaleerawangkan antimicrobialactivityofthegreenteapolyphenolepigallocatechin3gallateegcgagainstclinicalisolatesofmultidrugresistantivibriocholeraei